| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |